Hallal David (CIK 0001457477)

Latest company ownership

Shares held
17,533,884
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 19, 2022 Oct 21, 2022 Kalaris Therapeutics, Inc. Director Sell 16.3 -600,000 -21.34% ✗ $5.1M
Sep 29, 2022 Sep 30, 2022 Kalaris Therapeutics, Inc. Director Sell 17.5 -400,000 -12.52% ✗ $2.9M
Jul 21, 2022 Jul 21, 2022 Kalaris Therapeutics, Inc. Director Sell 57.5 -4,227 -0.02% ✓ $22.5K
Jun 3, 2022 Jun 6, 2022 Kalaris Therapeutics, Inc. Director Sell 48.8 -65,725 -0.38% ✓ $241.1K
Apr 21, 2022 Apr 22, 2022 Kalaris Therapeutics, Inc. Director Sell 57.5 -4,227 -0.02% ✓ $24.8K
Mar 10, 2022 Mar 11, 2022 Kalaris Therapeutics, Inc. Director Sell 46.3 -65,725 -0.38% ✓ $491.8K
Jan 24, 2022 Jan 25, 2022 Kalaris Therapeutics, Inc. Director Sell 47.5 -17,100 -0.10% ✗ $136.9K